These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2542580)

  • 1. Detection of murine cytomegalovirus DNA in circulating leukocytes harvested during acute infection of mice.
    Bale JF; O'Neil ME
    J Virol; 1989 Jun; 63(6):2667-73. PubMed ID: 2542580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biphasic viremia and viral gene expression in leukocytes during acute cytomegalovirus infection of mice.
    Collins TM; Quirk MR; Jordan MC
    J Virol; 1994 Oct; 68(10):6305-11. PubMed ID: 8083970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis of murine cytomegalovirus ocular infection. Anterior chamber inoculation.
    Bale JF; O'Neil ME; Lyon B; Perlman S
    Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1575-81. PubMed ID: 2167300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of murine cytomegalovirus infection: the macrophage as a permissive cell for cytomegalovirus infection, replication and latency.
    Brautigam AR; Dutko FJ; Olding LB; Oldstone MB
    J Gen Virol; 1979 Aug; 44(2):349-59. PubMed ID: 230287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative measurement of infectious murine cytomegalovirus genomes in real-time PCR.
    Wheat RL; Clark PY; Brown MG
    J Virol Methods; 2003 Sep; 112(1-2):107-13. PubMed ID: 12951218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of acute murine cytomegalovirus infection in resistant and susceptible strains of mice.
    Mercer JA; Spector DH
    J Virol; 1986 Feb; 57(2):497-504. PubMed ID: 3003382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine cytomegalovirus genomic material in marrow cells: relation to altered leukocyte counts during sublethal infection of mice.
    Bale JF; O'Neil ME; Giller R; Perlman S; Koszinowski U
    J Infect Dis; 1987 Feb; 155(2):207-12. PubMed ID: 3027192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine cytomegalovirus ocular infection in immunocompetent and cyclophosphamide-treated mice. Potentiation of ocular infection by cyclophosphamide.
    Bale JF; O'Neil ME; Folberg R
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1749-56. PubMed ID: 1851731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latent murine cytomegalovirus DNA in splenic stromal cells of mice.
    Pomeroy C; Hilleren PJ; Jordan MC
    J Virol; 1991 Jun; 65(6):3330-4. PubMed ID: 1851880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice.
    Bukowski JF; Woda BA; Welsh RM
    J Virol; 1984 Oct; 52(1):119-28. PubMed ID: 6207307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections.
    Mercer JA; Wiley CA; Spector DH
    J Virol; 1988 Mar; 62(3):987-97. PubMed ID: 2828694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide increases the amount of murine cytomegalovirus-DNA in mice latently infected with the virus.
    Okada K; Tanaka K; Noda S; Okazaki M; Koga Y
    Arch Virol; 1999; 144(12):2273-90. PubMed ID: 10664384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute murine cytomegalovirus infection induces lethal hepatitis.
    Shanley JD; Biczak L; Forman SJ
    J Infect Dis; 1993 Feb; 167(2):264-9. PubMed ID: 8380608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.
    Lawson CM; Grundy JE; Shellam GR
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1987-98. PubMed ID: 2841411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in replication of low-passage MCMV HaNa1 in BALB/c, C57BL/6 and NOD mice and role of different branches of immunity in susceptibility.
    Xiang J; Zhang S; Leclercq G; Nauwynck H
    Virus Res; 2016 Aug; 221():38-46. PubMed ID: 27173788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of cytomegalovirus DNA by blot hybridization in blood leukocytes of viremic patients.
    Saltzman RL; Quirk MR; Mariash CN; Jordan MC
    J Virol Methods; 1990 Oct; 30(1):67-77. PubMed ID: 1964941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice.
    Yuhasz SA; Dissette VB; Cook ML; Stevens JG
    Virology; 1994 Jul; 202(1):272-80. PubMed ID: 8009839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
    Morello CS; Cranmer LD; Spector DH
    J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cytomegalovirus infection during childhood: detection of viral DNA in peripheral blood by means of polymerase chain reaction.
    Shibata M; Morishima T; Terashima M; Kimura H; Kuzushima K; Hanada N; Nishikawa K; Watanabe K
    Med Microbiol Immunol; 1990; 179(5):245-53. PubMed ID: 1964487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latency, without persistence, of murine cytomegalovirus in the spleen and kidney.
    Pollock JL; Virgin HW
    J Virol; 1995 Mar; 69(3):1762-8. PubMed ID: 7853515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.